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Abstract:
Introduction: Community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) has
emerged as the most common cause of skin and soft-tissue infections (SSTI) in the United
States. A nearly three-fold increase in SSTI visit rates had been documented in the nation’s
emergency departments (ED). The objective of this study was to determine characteristics
associated with ED performance of incision and drainage (I+D) and use of adjuvant antibiotics in
the management of skin and soft tissue infections (SSTI). Methods: Cross-sectional study of the
National Hospital Ambulatory Medical Care Survey, a nationally representative database of ED
visits from 2007-09. Demographics, rates of I+D, and adjuvant antibiotic therapy were described.
We used multivariable regression to identify factors independently associated with use of I+D
and adjuvant antibiotics.Results: An estimated 6.8 million (95% CI: 5.9-7.8) ED visits for SSTI
were derived from 1,806 sampled visits; 17% were for children <18 years of age and most visits
were in the South (49%). I+D was performed in 27% (95% CI 24-31) of visits, and was less
common in subjects <18 years compared to adults 19-49 years (p<0.001), and more common in
the South. Antibiotics were prescribed for 85% of SSTI; there was no relationship to performance
of I+D (p=0.72). MRSA-active agents were more frequently prescribed after I+D compared to non-
drained lesions (70% versus 56%, p<0.001). After multivariable adjustment, I+D was associated
with presentation in the South (OR 2.36; 95% CI 1.52-3.65 compared with Northeast), followed by
West (OR 2.13; 1.31-3.45), and Midwest (OR 1.96; 1.96-3.22).Conclusion:Clinical management
of most SSTIs in the U.S. involves adjuvant antibiotics, regardless of I+D. Although not necessarily
indicated, CA-MRSA effective therapy is being used for drained SSTI. [West J Emerg Med.
2014;15(4):491–498.]
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Introduction: Community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) has 
emerged as the most common cause of skin and soft-tissue infections (SSTI) in the United States. 
A nearly three-fold increase in SSTI visit rates had been documented in the nation’s emergency 
departments (ED). The objective of this study was to determine characteristics associated with ED 
performance of incision and drainage (I+D) and use of adjuvant antibiotics in the management of 
skin and soft tissue infections (SSTI).  
Methods: Cross-sectional study of the National Hospital Ambulatory Medical Care Survey, a 
nationally representative database of ED visits from 2007-09. Demographics, rates of I+D, and 
adjuvant antibiotic therapy were described. We used multivariable regression to identify factors 
independently associated with use of I+D and adjuvant antibiotics. 
Results: An estimated 6.8 million (95% CI: 5.9-7.8) ED visits for SSTI were derived from 1,806 
sampled visits; 17% were for children <18 years of age and most visits were in the South (49%). 
I+D was performed in 27% (95% CI 24-31) of visits, and was less common in subjects <18 years 
compared to adults 19-49 years (p<0.001), and more common in the South. Antibiotics were 
prescribed for 85% of SSTI; there was no relationship to performance of I+D (p=0.72). MRSA-active 
agents were more frequently prescribed after I+D compared to non-drained lesions (70% versus 
56%, p<0.001). After multivariable adjustment, I+D was associated with presentation in the South 
(OR 2.36; 95% CI 1.52-3.65 compared with Northeast), followed by West (OR 2.13; 1.31-3.45), and 
Midwest (OR 1.96; 1.96-3.22). 
Conclusion:Clinical management of most SSTIs in the U.S. involves adjuvant antibiotics, regardless 
of I+D. Although not necessarily indicated, CA-MRSA effective therapy is being used for drained 
SSTI. [West J Emerg Med. 2014;15(4):491–498.] 
INTRODUCTION
Background
Community-associated methicillin resistant 
Staphylococcus aureus (CA-MRSA) has emerged as the most 
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common cause of skin and soft-tissue infections (SSTI) in the 
United States, especially in purulent skin abscess. In many 
areas of the country, MRSA prevalence is as high as 75-80% 
among cultured SSTI.1–7 This epidemic has disproportionately 
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affected patients presenting to the emergency department 
(ED), where a nearly three-fold increase in SSTI visit rates 
had been documented in adults and children, and increases 
in both skin abscesses and cellulitis have been observed.8–10 
Although the rise in SSTIs due to MRSA has led to an 
increase in hospitalizations and, in some cases, invasive 
disease, the majority of skin infections are managed in 
ambulatory settings, including the ED.8,9 
Importance
The rise in SSTIs and CA-MRSA has led to significant 
changes in clinical ED practice. First, the determination of 
the presence of an abscess, as opposed to a cellulitis, is an 
increasingly frequent diagnostic challenge faced by emergency 
physicians (EP). As a result, many EPs are using formal or 
bedside ultrasonography for diagnostic evaluation of SSTI.11–13 
Also, due to the increasing number of patients presenting 
with purulent abscess, incision and drainage (I+D) procedures 
are more frequently indicated. I+D can be especially time 
consuming in children, as procedural sedation is often 
required, which also carries inherent risk to the patient.14,15 
Therapeutic decisions regarding use of antibiotic therapy are 
also changing. Soon after the emergence of CA-MRSA, use of 
agents “active” against this organism, such as clindamycin and 
trimethoprim-sulfamethoxazole (TMP-SMX) has increased, 
while ß-lactam antibiotics, which provide empiric therapy 
for methicillin-sensitive S. aureus (MSSA) and ß-hemolytic 
streptococcus (BHS) are prescribed less frequently.8,14–16 The 
implications of this shift in antibiotic therapy, however, are 
uncertain. Despite a growing body of evidence suggesting 
that antibiotics may not be necessary for adequately drained 
skin abscesses,17–19 studies have found that use of adjuvant 
antibiotics is common.14,20 These various studies have reported 
changes in clinical practice with respect to treatment of SSTI, 
although many of these consist of single institution and survey 
studies, and isolated pediatric or adult data. 
Goals of this Investigation
The objective of our study was to investigate national 
practice patterns of SSTI management in the ED. Specifically, 
we determined national rates of I+D use and patterns of 
antibiotic prescribing for ED patients with SSTIs. 
METHODS
Study Design, Setting, and Subjects
We analyzed data from the National Hospital Ambulatory 
Medical Care Survey (NHAMCS), a cross-sectional survey 
conducted annually by the National Center for Health 
Statistics (NCHS).21 The survey is used to collect information 
about patient demographics, diagnoses, medications 
prescribed, and procedures performed on a nationally 
representative sample of ED visits in the U.S. To collect data 
from a nationally representative sample of visits, the NCHS 
administers the survey at participating hospitals using a four-
stage probability sampling design, after sampling geographic 
primary sampling units (PSUs), the NCHS samples hospitals 
within PSUs, emergency service areas and in-scope 
ambulatory surgery locations within hospitals, and visits 
within these settings. Data from sampled visits are collected 
by hospital staff, who were trained by and maintained contact 
with trained field representatives during the reporting period. 
The NCHS provides probability weights – equal to the 
inverse probability of any visit being sampled – that allow 
for the generation of nationally representative estimates 
using data collected in the NHAMCS. The study was granted 
exemption from the institutional review board review. 
Methods and Measurements
In our analysis, we combined data collected in the 
NHAMCS between 2007 and 2009. The analysis was 
restricted to initial visits for an SSTI; we excluded visits 
for follow up. Methodology for identification of SSTI in 
NHAMCS mirrored that of previous published studies: we 
identified visits for SSTI using International Classification 
of Disease, Ninth Revision, Clinical Modification (ICD-9-
CM) codes for skin and soft issue infection (680.xx-682.
xx), which includes carbuncle, folliculitis, cellulitis, and 
skin abscess.8,9,22 Although the NHAMCS allows for up to 
three diagnosis codes to be assigned to a visit, we defined 
SSTI based upon the primary diagnosis listed. Study 
subjects included patients of all ages, and we analyzed 
participants’ demographic data including race, gender, 
and insurance status. Location of ED care, in terms of 
geographic region, was also collected in the NHAMCS and 
described in our study. Geographic regions were defined 
using US Census Track Regions, including the Northeast, 
South, Midwest, and West.
Details of ED visits, including performance of 
drainage procedures, diagnostic testing, ED disposition, 
and prescription antibiotic use were recorded at each visit. 
Performance of diagnostic testing—including complete 
blood count, blood culture, or wound culture–was indicated 
via check box in the patient record form. We dichotomized 
ED disposition as outpatient management or hospitalization, 
which included admission to an inpatient ward or 
observation unit. Antibiotics were categorized using the 
Multum Lexicon Therapeutic Classification System. Starting 
with the 2006 surveys, the NHCS began to code drugs using 
the Multum system, which characterizes drugs using a three-
tiered hierarchy. For example, beta-lactamase inhibitors are 
a “level 3” category of drugs within the “level 2” category 
that includes all penicillins. Penicillins, in turn, belong to 
a “level 1” category that includes all anti-infectives. In 
addition to broad categories, the Multum system allows 
for identification of specific drugs (e.g., clindamycin). 
For the purposes of our analysis, we grouped antibiotics 
into the following categories: anti-MRSA (trimethoprim-
sulfamethoxazole, clindamycin, daptomycin, tetracyclines, 
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vancomycin, linezolid, and tigecycline), β-lactam (penicllins, 
cephalosporins, and carbapenems), and other (rifampin, 
macrolides, aminoglycosides, and quinolones).
 
Statistical Analysis
All statistical analyses took into account the complex 
sampling design of the NHAMCS, including sample weights, 
stratification, and clustering variables. Description of study 
subjects and ED visits were made using standard descriptive 
statistics. We made univariate comparisons using the χ2-test 
for proportions, and p-values were reported with a significance 
level of <0.05. Specifically, we compared patient characteristics, 
diagnostic testing, and adjuvant antibiotic prescription between 
patients with and without an incision and drainage procedure 
performed. To identify independent patient characteristics 
associated with clinical care of SSTI and to account for 
potential confounding, we performed multivariable logistic 
regression. Two regression models were created: one to identify 
factors independently associated with performance of I+D, 
and a second to assess factors associated with prescribing 
of adjuvant antibiotics among subjects that had a drainage 
procedure. We reported values as adjusted odds ratios (OR) with 
95% confidence intervals (CI). We conducted all analyses using 
STATA 11 software (Stata Corp, College Station, TX).
 
RESULTS
Characteristics of Study Subjects
During the study period, based on a sample of 1,806 
actual visits in the NHAMCS database, there were an 
estimated 6.82 (95% CI: 5.88-7.75) million initial ED visits 
for SSTI in the U.S. This corresponds to an average of 2.27 
million visits annually.  Survey weighted demographics of the 
study population are presented in Table 1. Most study subjects 
were above the age of 18 years, Caucasian, and privately 
insured. The largest number of SSTIs occurred among patients 
in the 18-49 year age group, while children (<18 years) had 
the fewest. The rate of ED visitation for SSTI was highest in 
the southern U.S., compared to other regions (Table 1).
Emergency Department Clinical Care for SSTI 
Among visits for SSTI, an estimated 27% (95% CI: 
Table 1. Characteristics of initial emergency department (ED) visits for skin and soft tissue infections (SSTI) among study patients*†
 
Estimated survey 
weighted ED visits 
 (in millions)
All SSTI††
 (n=1,806)
No I+D††
(n=1,311)
I+D††
 (n=495)
p-value 
(X2)
Year
2007 2.03 30% 31% 27%
2008 2.47 36% 35% 39% 0.51
2009 2.32 34% 34% 34%
Age (years)
<18 1.16 17% 18% 15%
18-49 3.89 57% 53% 69% <0.0001
>49 1.77 26% 29% 16%
Race
White 4.84 71% 77% 57% <0.0001
Nonwhite 1.98 29% 23% 43%
Gender
Male 3.48 51% 50% 52% 0.64
Female 3.34 49% 50% 48%
Insurance status
Private 4.57 67% 67% 70% 0.23
Public/other 2.25 33% 33% 30%
US census track region
Northeast 1.09 16% 19% 9%
Midwest 1.09 16% 17% 16%
South 3.34 49% 45% 58% <0.001
West 1.30 19% 19% 18% 
*Survey weights applied; †Totals may be >100%; ††Proportions represent total within each column; I+D, incision and drainage.
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24-31) had an I+D procedure performed. Performance of 
I+D occurred more often in patients who were 18-49 years 
of age (p<0.001), non-white, and when treated in the South 
(p<0.001).  Wound cultures were performed in 16% of visits 
for SSTI, and they were performed more frequently when I+D 
was also performed (31%) than when I+D was not performed 
(11%) (p<0.001). Among the study population, ancillary 
diagnostic testing was obtained in many patients: 27% had a 
complete blood count and 12% had a blood culture obtained in 
the ED; each were more likely to be obtained in patients when 
an I+D was not performed (p<0.001). The majority of patients 
were cared for as outpatients, with only 15% of study subjects 
hospitalized after the ED visit. Hospitalization for SSTI was 
less common when I+D was performed during the ED visit 
(5%) than when I+D was not performed (19%) (p<0.001).
Overall, 85% of patients with SSTI received an antibiotic 
prescription. There was no difference in the rate of antibiotic 
use between those who did or did not receive an I+D (84% 
versus 85%, p=0.72). However, there were significant 
differences in antibiotic choices based on whether an I+D 
was performed. The majority (70%) of patients who had 
I+D were prescribed an anti-MRSA antibiotic, compared 
to 56% of those not receiving I+D (p<0.0001) (Table 2). 
Combination therapy, with prescription of anti-MRSA and 
beta-lactam antibiotics, was used in 15% of subjects; there 
was no association between the use of combination therapy 
and performance of a drainage procedure (p=0.08). 
Multivariable Analysis
After adjusting for other potentially confounding factors, 
performance of I+D was significantly associated with patient 
age of 18-49 years, non-white race, and care in regions 
other than the U.S. Northeast, with the strongest association 
observed in the South. Among patients undergoing I+D, 
adjuvant antibiotic therapy was only associated with patients 
treated in the South (OR 3.23; 1.41-7.40 compared with the 
Northeast) (Table 3). 
DISCUSSION
This study provides a nationally representative overview 
of ED management for patients with SSTIs. While I+D 
is considered the mainstay of therapy for purulent SSTI, 
it is performed in less than half of children presenting to 
the ED for an SSTI. Overall drainage procedure are less 
commonly performed for children <18 years compared to 
adults 18-48 years of age, and more commonly performed 
in non-white patients, and in those presenting outside of the 
Northeast. Furthermore, adjuvant antibiotic use for SSTIs is 
commonplace, regardless of whether or not I+D is performed. 
Though the majority of subjects are receiving CA-MRSA 
active therapy, consistent with current epidemiology, current 
evidence indicates that antibiotic therapy may be unnecessary 
for purulent abscesses that are adequately drained.
I+D remains the mainstay of treatment for purulent skin 
abscesses, irrespective of patient characteristics or site of 
care.16,23,24 However, the results of our study demonstrate that 
for SSTIs presenting to the ED, I+D appears to be less likely to 
be performed in pediatric patients and white patients. While the 
ED is often the preferred site of care for potentially drainable 
SSTI, the pediatric population is less likely to receive an I+D. 
It is possible, though unlikely, that the prevalence of cellulitis 
is higher than abscess in the pediatric population; current 
administrative databases do not permit discrimination between 
ICD-9 codes for these infections. Factors such as reluctance 
to perform an empiric I+D procedure because of incurred pain 
or need for procedural sedation, or the limited use of bedside 
ultrasonography in children, may explain this finding, in part. 
For example, sedation possesses inherent logistical challenges 
in the ED setting, such as time required and associated risks; in 
addition, sedation is more likely to be employed in academic 
settings, which is not representative of the majority of ED 
visits across the U.S.15 In addition, bedside ultrasonography 
is underused in pediatric patients,25,26 though it has proven 
benefit in adults; abscesses are often underdiagnosed compared 
with examination, and therefore may not receive I+D.12,27 
With respect to patient race and performance of I+D, there 
is suggestion that CA-MRSA and SSTI are more common in 
blacks, as compared to other races,28–31 which accounts for 
differences in the performance of I+D; CA-MRSA infection is 
related to increased risk of abscess formation, and mirrors this 
epidemiologically.2,6,29
Several geographic differences with respect to SSTI 
management were elicited in our study, even after adjustment 
for multiple patient factors, including age, race, and insurance 
status. Patients with SSTI treated in EDs outside of the 
Northeast underwent I+D more frequently: compared with the 
Table 2. Antibiotics prescribed for study subjects.
Variable Overall No I+D I+D p-valuee
Any antibiotic usea 85% 85% 84% 0.72
Anti-MRSA monotherapyb 43% 38% 57% <0.0001
β-lactam monotherapyc 23% 27% 13% <0.0001
Anti-MRSA + β-lactam 
combination 15% 16% 11% 0.08
Other antibioticsd 4% 5% 3% 0.18
No antibiotics 15% 15% 16% 0.72
 
a Values may not sum accurately as a result of rounding
b Includes sulfonamides, tetracyclines, clindamycin, vancomycin, 
linezolid, daptomycin, and tigecyclin.
c Includes cephalosporins, penicillins, and carbapenems.
d Includes macrolides, aminoglycosides, quinolones, and rifampin.
e Chi-square comparisons of No I+D with I+D 
I+D, incision and drainage
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Northeast, patients treated in the South were twice as likely 
to have an I+D performed and three times as likely to receive 
adjuvant antibiotics after the I+D. However, it is unclear 
whether a true association exists between region and treatment 
strategies. It should be noted that the prevalence of CA-MRSA 
is highest in urban centers located in the South (Atlanta, 
Houston, Dallas), in the Midwest (Chicago, St. Louis), and 
in the West (San Francisco, Los Angeles), with rates as high 
80-85% in many of these locations.1,3,6,7,19,29,30 Meanwhile, 
many centers in the Northeast (New York, Philadelphia) 
documented rates of MRSA less than 70%.29,32 Nonetheless, 
while the incidence of skin abscesses is related to CA-
MRSA prevalence, it is unclear if this regional relationship 
purely reflects ED visitation, population demographic, or 
actual differences in clinical care. These findings should be 
interpreted in light of the fact that our ability to identify skin 
abscess was based on best literature-supported methods for 
administrative data; the true clinical scenario of abscess versus 
cellulitis cannot be assessed, and the prevalence of CA-MRSA 
in cellulitis is not known.  
Our study confirms the frequent use of systemic antibiotics 
for SSTIs managed in the ED, which was not influenced by 
the performance of I+D: approximately 85% of all patients 
received adjuvant antibiotic therapy. This finding has important 
implications. For some patients, especially children among 
whom barriers to performing drainage exist, ED physicians 
may be using antibiotic therapy instead of performing a 
drainage procedure. It cannot be overemphasized that adjuvant 
antibiotics are not a substitute for I+D when treating purulent 
skin abscesses, and the assumption that antibiotic therapy 
alone will adequately treat a skin abscess might increase 
the possibility of treatment failure. Moreover, this high rate 
of adjuvant antibiotic use suggests that ED physicians are 
reluctant to withhold antibiotic therapy, despite recent evidence 
demonstrating a general lack of efficacy of this practice.18,19 
However, recent evidence suggests that I+D alone is sufficient 
for most ED patients with uncomplicated abscess. Chen et al 
demonstrated that failure rates between pediatric skin abscesses, 
in a study population with 70% CA-MRSA, did not differ when 
treated with adjuvant clindamycin compared to the non-MRSA 
active cephalexin (3 versus 6%, p=0.50).17 The most salient of 
these was a methodologically sound, non-inferiority study of 
Table 3. Multivariable regression analyses of factors associated with performance of incision and drainage and with receipt of adjuvant 
antibiotics coupled with incision and drainage in patients with skin and soft-tissue infections.
% Receiving I+D AOR (95% CI) % Receiving antibiotics AOR (95% CI)
Year
2007 25% 1.00 91% 1.00
2008 29% 1.30 (0.90-1.90) 80% 0.57 (0.25-1.29)
2009 27% 1.34 (0.96-1.87) 83% 0.49 (0.23-1.04)
Age
<18 24% 1.00 87% 1.00
18-49 32% 1.77 (1.23-2.55) 84% 0.46 (0.12-1.70)
>49 17% 0.94 (0.60-1.49) 81% 0.42 (0.10-1.66)
Race
White 22% 1.00 85% 1.00
Nonwhite 41% 2.34 (1.71-3.19) 83% 0.77 (0.43-1.40)
Sex
Male 28% 1.00 85% 1.00
Female 26% 0.86 (0.63-1.18) 83% 1.09 (0.58-2.03)
Insurance status
Private 25% 0.96 (0.74-1.25) 84% 0.92 (0.47-1.80)
Public/other 28% 1.00 85% 1.00
US census region
Northeast 15% 1.00 72% 1.00
Midwest 26% 1.96 (1.19-3.22) 78% 1.90 (0.62-5.81)
South 32% 2.36 (1.52-3.65) 89% 3.23 (1.41-7.40)
West 26% 2.13 (1.31-3.45) 78% 1.31 (0.49-3.52) 
I+D, incision and drainage; AOR, Adjusted Odds Ratio  
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TMP-SMX versus placebo in drained skin abscess, by Duong 
et al in 2010. Treatment failure in the placebo group was 5.3%, 
compared with 4.1% in the TMP-SMX group (mean difference 
1.2% 95% CI: -∞ to 6.8).19 These results, in conjunction with 
current evidence and national guideline recommendations, 
strongly suggest that adjuvant antibiotic therapy does not 
or only minimally improves cure rates compared with 
placebo or use of an agent that was inactive against the 
pathogen.1,3,18,19,24,24,33 These findings support the need for 
knowledge dissemination of these studies and guideline 
recommendations, continued surveillance of ED prescribing 
practices, and more judicious use of adjuvant therapy. 
On the other hand, our findings suggest that EPs do 
appear to be tailoring their antibiotic selection patterns based 
on the epidemiology of the infection. Use of anti-MRSA 
therapy, including clindamycin and TMP-SMX, was higher 
for patient visits where I+D was performed. This is consistent 
with the likely differences in pathogens between purulent 
and nonpurulent SSTI: purulent SSTI such as abscesses are 
more likely to be caused by S. aureus, whereas nonpurulent 
cellulitis and erysipelas are more likely to be caused by 
BHS.29,34,35 Therefore, if antibiotics are deemed necessary 
for the management of purulent SSTI, an antibiotic with 
activity against MRSA is generally recommended, typically 
clindamycin or TMP-SMX, based on local resistance 
patterns.16,24 With respect to non-purulent SSTI, a recent study 
of inpatients residing in a high-MRSA prevalence community 
demonstrated that BHS was the causative agent in 73% of 
cases of non-purulent cellulitis.34 Therefore, use of therapy with 
activity against BHS for cellulitis, especially beta-lactams or 
clindamycin is prudent, as TMP-SMX alone is not considered 
adequate and has been associated with treatment failure when 
used as monotherapy for non-drained SSTIs.10
Differences exist with respect to ancillary testing and 
ED disposition for SSTIs, based on performance of I+D. In 
the setting of a known abscess, clinicians will be more likely 
to perform drainage without additional testing. Diagnosis 
of and treatment of skin abscess is more straightforward as 
compared to non-drained lesions, where cellulitis, or even 
deeper skin lesions may be a consideration. As a result, it 
is logical that patients with non-drained SSTI were more 
likely to receive laboratory testing, including complete blood 
counts and blood cultures. While there may be an effect from 
institutional differences, these findings seem justified, as 
patients with non-drained SSTIs were also four-times as likely 
to be admitted to the hospital for continued therapy. Although 
many physicians continue to favor use of serum testing in 
SSTI management.14 It should be noted that serum testing adds 
little to the management of SSTI, and rates of bacteremia in 
cellulitis and skin abscess remain quite low.36 Notably, wound 
cultures were not obtained in the majority of SSTI even after 
drainage. This is incongruent with current recommendations 
from the IDSA and CDC, which recommend wound culture in 
the management of SSTI to monitor for therapeutic failure, and 
track current S. aureus epidemiolgy.16,24
LIMITATIONS
Among the limitations to our findings is the use of 
large-scale administrative data from NHAMCS, as has 
been well documented.37 Specifically, the NHAMCS 
survey does not include some potentially important clinical 
information that could influence treatment decisions 
around I+D or antibiotic use, including lesion size or prior 
history of MRSA or SSTI. As a result, we are not able to 
fully evaluate the appropriateness of clinical management. 
NHAMCS is also limited by its use of ICD-9 codes for 
diagnosis. In the case of SSTI, ICD-9 does not distinguish 
between cellulitis and abscess, and use of ICD-9 codes for 
SSTI and procedure codes of I+D to identify abscesses is 
limited and prone to misclassification.  Additionally, the 
limited sample of patients did not permit sub-analysis of 
our study population by smaller increments of age, and it 
is possible that further differences exist in management of 
younger pediatric patients compared to older adolescents. 
In addition, regional differences found in our study may 
not be accurate, as NHAMCS coding and Census Track 
Regions results in overrepresentation of the South in 
terms of ED visits. Since our data source did not contain 
results or microbiologic testing for ED patients with 
SSTI, we could not confirm this relationship between CA-
MRSA prevalence and the need for incision and drainage. 
Although relatively unlikely, particularly because we 
restricted our analysis to initial ED visits, some patients 
may have undergone I+D previously in an office setting, 
which would not have been captured by the NHAMCS 
dataset. Finally, although we found differences in clinical 
care across the large geographic areas of U.S. Census Track 
Region, we could not comment on actual care provided, or 
account for potentially important differences across smaller 
geographic areas.
CONCLUSION
In spite of current literature disputing the need for 
adjuvant antibiotic therapy for uncomplicated SSTI that 
has undergone I+D, this practice remains common in adults 
and children presenting to the ED for skin abscesses. While 
CA-MRSA active therapy for drained SSTI has increased 
concomitant with the rise in CA-MRSA, prescribing practices 
for non-drained SSTIs such as cellulitis reflect increased use 
of CA-MRSA active therapy, which may not be appropriate, 
as Group A Streptococcus remains prevalent. Meanwhile, 
the practice of serum testing for non-drained SSTI remains 
common, despite uncertainty in the diagnostic and therapeutic 
utility.  Nationally representative studies are essential 
for evaluating current practice for SSTI, and continued 
assessments of antibiotic therapy will be necessary to evaluate 
dissemination of evidence regarding appropriate use of 
diagnostics and adjuvant antibiotics for SSTIs.
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